Clinical data | |
---|---|
Trade names | Declomycin |
Other names | RP-10192, demethylchlortetracycline |
AHFS/Drugs.com | Monograph |
MedlinePlus | a682103 |
Routes of administration | Oral |
ATC code | |
Legal status | |
Legal status |
|
Pharmacokinetic data | |
Bioavailability | 60–80% |
Protein binding | 41–50% |
Metabolism | Hepatic |
Elimination half-life | 10–17 hours |
Excretion | Renal |
Identifiers | |
| |
CAS Number | |
PubChem CID | |
DrugBank | |
ChemSpider | |
UNII | |
KEGG | |
ChEBI | |
ChEMBL | |
CompTox Dashboard (EPA) | |
ECHA InfoCard | 100.004.396 |
Chemical and physical data | |
Formula | C21H21ClN2O8 |
Molar mass | 464.86 g·mol−1 |
3D model (JSmol) | |
| |
| |
(verify) |
Demeclocycline (INN, BAN, USAN, brand name Declomycin) is a tetracycline antibiotic which was derived from a mutant strain of Streptomyces aureofaciens.[1][2]